2.48% Medicare Advantage Hike Adds $13B, CVS Shares Jump 5.8%
CMS finalized a 2.48% Medicare Advantage payment increase for 2027, boosting annual funding by $13 billion. CVS Health shares advanced 5.8% as investors repriced earnings expectations on the stronger-than-expected rate uplift and deferred risk-adjustment changes.
1. Payment Increase and Funding Impact
Centers for Medicare and Medicaid Services finalized a 2.48% payment increase for Medicare Advantage plans in 2027, up from the near-flat 0.09% initially proposed in January, injecting roughly $13 billion in additional funding next year.
2. CVS Stock Reaction
Shares of CVS Health rallied 5.8% on the announcement as investors accelerated revisions to earnings forecasts, mirroring similar gains of 6.6% and 11% in UnitedHealth and Humana stocks.
3. Deferred Risk-Adjustment Changes
CMS opted to defer specific updates to the risk adjustment model for 2027, signaling a measured regulatory approach that could ease compliance costs and support margin rebuilding for private insurers.
4. Outlook for CVS Health
The stronger-than-expected rate finalization and delayed structural changes are likely to stabilize margin pressure and set a more constructive earnings trajectory for CVS Health over the next two years.